Lunai Bioworks Inc.
LNAI
$1.02
-$0.15-12.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.96% | -44.79% | 20.37% | -36.05% | 69.32% |
| Depreciation & Amortization | 4.82% | 5.61% | -3.31% | 18.68% | 11.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.71% | -52.54% | 6.47% | -35.57% | 37.47% |
| Operating Income | 24.71% | 52.54% | -6.47% | 35.57% | -37.47% |
| Income Before Tax | -705.59% | 100.32% | -60.13% | -381.87% | 32.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -705.59% | 100.32% | -60.13% | -381.87% | 32.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -705.59% | 100.32% | -60.13% | -381.87% | 32.19% |
| EBIT | 24.71% | 52.54% | -6.47% | 35.57% | -37.47% |
| EBITDA | 24.88% | 52.74% | -6.54% | 35.74% | -37.65% |
| EPS Basic | -589.73% | 100.22% | 34.84% | -98.45% | 73.70% |
| Normalized Basic EPS | 48.57% | 67.79% | 58.11% | 73.41% | 34.58% |
| EPS Diluted | -584.62% | 100.21% | 34.84% | -98.45% | 73.50% |
| Normalized Diluted EPS | 48.57% | 68.10% | 58.11% | 73.41% | 34.58% |
| Average Basic Shares Outstanding | 16.80% | 48.59% | 145.74% | 142.81% | 157.80% |
| Average Diluted Shares Outstanding | 16.80% | 50.05% | 145.74% | 142.81% | 157.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |